Jason Loo

Dr. Jason Loo

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
Jhi Biau FooJhi Biau Foo
Jhi Biau Foo
LNLi Shan Ng
Li Shan Ng
JLJi Hui Lim
Ji Hui Lim
PTPau Xien Tan
Pau Xien Tan
YLYan Zhi Lor
Yan Zhi Lor
CHCw How
Cw How
Cu(SBCM) 2 binds to DNA topoisomerase I, which, in turn, induces cell cycle arrest and apoptosis in MCF-7 breast cancer cells, possibly via p53 signalling pathway.

16 November 2016 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
JTJohn J. L. Tiong
John J. L. Tiong
JLJason Loo
Jason Loo
CMChun-Wai Mai
Chun-Wai Mai
Antimicrobial stewardship (AMS) has been touted as one of the key strategies required in tackling worldwide escalation of antibiotic resistance. Although AMS has optimized antibiotic usage and reduced the incidence of resistance development in some regions, its full global potential has been curtailed by various AMS-impeding factors. This article seeks to highlight in a detailed perspective, the key challenges that hamper global AMS endeavors, some of which include the paucity of effective implementation strategies that cater for the challenging settings of developing nations, the slow response of governments, uncoordinated AMS activities as well as implementation fragmentation across different sectors and countries. The authors of this article call upon all stakeholders to pay attention to these seemingly obvious but often under-addressed problems. If left unresolved, this may render all current and future AMS initiatives pointless.

15 April 2019 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Closed access
PDF file
MYMei Qian Yau
Mei Qian Yau
AEAbigail L. Emtage
Abigail L. Emtage
NCNathaniel J. Y. Chan
Nathaniel J. Y. Chan
SDStephen W. Doughty
Stephen W. Doughty
JLJason Loo
Jason Loo

1 October 2021 in Carbohydrate Research
Verified
Journal Article
Closed access
ZLZheng Yang Lee
Zheng Yang Lee
JLJason Loo
Jason Loo
AWAgustono Wibowo
Agustono Wibowo
MMMohd Fazli Mohammat
Mohd Fazli Mohammat
Jhi Biau FooJhi Biau Foo
Jhi Biau Foo

30 March 2022 in Toxicology Reports
Verified
Journal Article
Open access
SLSharoen Yu Ming Lim
Sharoen Yu Ming Lim
JLJason Loo
Jason Loo
MAMustafa Alshagga
Mustafa Alshagga
Mohammed Abdullah AlshawshMohammed Abdullah Alshawsh
Mohammed Abdullah Alshawsh
COChin Eng Ong
Chin Eng Ong
PYPan Yan
Pan Yan
Cathinone is the psychostimulatory major active ingredient of khat (Catha edulis Forsk) and are often co-abused with alcohols and polydrugs. With the increased consumption of khat and cathinones on a global scale, efforts should be channelled into understanding and minimising the excruciating effects of possible khat-drug interactions. This study aimed to determine the in vitro inhibitory effects of cathinone on CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2 and CYP3A5 and the in silico identification of their type of interactions and residues involved. The activities of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, CYP2J2 and CYP3A5 were examined by fluorescence based assays using recombinant cDNA-expressed human CYPs in Vivid® P450 screening kits. Cathinone reversibly inhibited CYP1A2, CYP2A6 and CYP3A5 via competitive, uncompetitive and noncompetitive modes with inhibition constant (Ki) values of 57.12, 13.75 and 23.57 µM respectively. Cathinone showed negligible inhibitory effects on CYP2B6, CYP2C8, CYP2C19, CYP2E1 and CYP2J2. Cathinone showed negligible time dependent inhibition on all 8 CYPs. Docking studies was performed on cathinone with CYP1A2, CYP2A6 and CYP3A5 following their inhibition in vitro. Cathinone is bound to a few key amino acid residues in the active sites while π-π interactions are formed in aromatic clusters of CYP1A2 and CYP3A5. These findings offer valuable reference for the use of cathinones and khat when combined with therapeutic drugs that are metabolised by CYP enzymes especially patients on medications metabolised by CYP1A2, CYP2A6 and CYP3A5.

1 March 2018 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
JLJason Loo
Jason Loo
AEAbigail L. Emtage
Abigail L. Emtage
KNKar Weng Ng
Kar Weng Ng
AYAlene S.J. Yong
Alene S.J. Yong
SDStephen W. Doughty
Stephen W. Doughty